company background image

Ekttitab Holding Company K.S.C KWSE:EKTTITAB Stock Report

Last Price


Market Cap







26 Sep, 2022


Company Financials
EKTTITAB fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health4/6

EKTTITAB Stock Overview

Ekttitab Holding Company K.S.C Public engages in the investment activities in Kuwait.

Ekttitab Holding Company K.S.C Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ekttitab Holding Company K.S.C
Historical stock prices
Current Share Priceد.ك0.011
52 Week Highد.ك0.024
52 Week Lowد.ك0.0088
1 Month Change-8.07%
3 Month Change-8.07%
1 Year Change-39.04%
3 Year Change-31.32%
5 Year Change-67.43%
Change since IPO-96.98%

Recent News & Updates

Shareholder Returns

EKTTITABKW Capital MarketsKW Market

Return vs Industry: EKTTITAB underperformed the KW Capital Markets industry which returned -1.7% over the past year.

Return vs Market: EKTTITAB underperformed the KW Market which returned 4% over the past year.

Price Volatility

Is EKTTITAB's price volatile compared to industry and market?
EKTTITAB volatility
EKTTITAB Average Weekly Movement10.7%
Capital Markets Industry Average Movement5.0%
Market Average Movement4.9%
10% most volatile stocks in KW Market9.5%
10% least volatile stocks in KW Market2.3%

Stable Share Price: EKTTITAB is more volatile than 90% of KW stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: EKTTITAB's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KW stocks.

About the Company

1999n/aMuhammad Al-Ayyoob

Ekttitab Holding Company K.S.C Public engages in the investment activities in Kuwait. The company was founded in 1999 and is headquartered in Kuwait City, Kuwait.

Ekttitab Holding Company K.S.C Fundamentals Summary

How do Ekttitab Holding Company K.S.C's earnings and revenue compare to its market cap?
EKTTITAB fundamental statistics
Market Capد.ك3.63m
Earnings (TTM)-د.ك1.95m
Revenue (TTM)د.ك8.17k


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EKTTITAB income statement (TTM)
Cost of Revenueد.ك0
Gross Profitد.ك8.17k
Other Expensesد.ك1.96m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)-0.0061
Gross Margin100.00%
Net Profit Margin-23,904.92%
Debt/Equity Ratio0.0%

How did EKTTITAB perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.


Is EKTTITAB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EKTTITAB?

Other financial metrics that can be useful for relative valuation.

EKTTITAB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue424.7x
Enterprise Value/EBITDA-1.8x
PEG Ration/a

Price to Book Ratio vs Peers

How does EKTTITAB's PB Ratio compare to its peers?

EKTTITAB PB Ratio vs Peers
The above table shows the PB ratio for EKTTITAB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average0.7x
WARBACAP Warba Capital Holding Company K.S.C.P
OSOUL Osoul Investment Company - K.S.C.P
BAYANINV Bayan Investment Holding Company (K.S.C)
UNICAP Unicap Investment and Finance Company K.S.C.P
EKTTITAB Ekttitab Holding Company K.S.C

Price-To-Book vs Peers: EKTTITAB is good value based on its Price-To-Book Ratio (0.4x) compared to the peer average (0.7x).

Price to Earnings Ratio vs Industry

How does EKTTITAB's PE Ratio compare vs other companies in the KW Capital Markets Industry?

Price-To-Book vs Industry: EKTTITAB is good value based on its Price-To-Book Ratio (0.4x) compared to the KW Capital Markets industry average (0.7x)

Price to Book Ratio vs Fair Ratio

What is EKTTITAB's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EKTTITAB PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.4x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate EKTTITAB's Price-To-Book Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of EKTTITAB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate EKTTITAB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate EKTTITAB's fair value for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Ekttitab Holding Company K.S.C forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Diversified Financials industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ekttitab Holding Company K.S.C has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Past Performance

How has Ekttitab Holding Company K.S.C performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EKTTITAB is currently unprofitable.

Growing Profit Margin: EKTTITAB is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: EKTTITAB is unprofitable, and losses have increased over the past 5 years at a rate of 5.9% per year.

Accelerating Growth: Unable to compare EKTTITAB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EKTTITAB is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (15.4%).

Return on Equity

High ROE: EKTTITAB has a negative Return on Equity (-19.97%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is Ekttitab Holding Company K.S.C's financial position?

Financial Health Score


Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: EKTTITAB's short term assets (KWD4.3M) exceed its short term liabilities (KWD3.5M).

Long Term Liabilities: EKTTITAB has no long term liabilities.

Debt to Equity History and Analysis

Debt Level: EKTTITAB is debt free.

Reducing Debt: EKTTITAB has not had any debt for past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EKTTITAB has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: EKTTITAB has less than a year of cash runway if free cash flow continues to grow at historical rates of 1.8% each year.

Discover healthy companies


What is Ekttitab Holding Company K.S.C current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate EKTTITAB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EKTTITAB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EKTTITAB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EKTTITAB's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as EKTTITAB has not reported any payouts.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Muhammad Al-Ayyoob

no data


Mr. Muhammad Salah Al-Ayyoob serves as Chief Executive Officer and Director at Ekttitab Holding Company K.S.C. (Public).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EKTTITAB?
Owner TypeNumber of SharesOwnership Percentage
General Public273,347,72785.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 2 shareholders own 14.21% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
Al Salam Group Holding Co., Asset Management Arm
28,485,006KWD324.7k0%no data
Al Madina Financial & Investment, Asset Management Arm

Company Information

Ekttitab Holding Company K.S.C Public's employee growth, exchange listings and data sources

Key Information

  • Name: Ekttitab Holding Company K.S.C Public
  • Ticker: EKTTITAB
  • Exchange: KWSE
  • Founded: 1999
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Implied Market Cap: د.ك3.632m
  • Shares outstanding: 318.62m
  • Website:


  • Ekttitab Holding Company K.S.C Public
  • Behbehani Complex
  • Floor 16
  • Kuwait City
  • 13028
  • Kuwait


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EKTTITABKWSE (Kuwait Stock Exchange)YesShare CapitalKWKWDJan 2006
EKTTITABDFM (Dubai Financial Market)YesShare CapitalAEAEDJan 2006

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/26 00:00
End of Day Share Price2022/09/26 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.